NeoCore Technology Co., Ltd. (TPEX:4131)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.35
-0.45 (-1.19%)
Mar 10, 2026, 1:33 PM CST
0.54%
Market Cap 1.49B
Revenue (ttm) 190.10M
Net Income (ttm) -20.46M
Shares Out 39.50M
EPS (ttm) -0.52
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 99,000
Average Volume 76,103
Open 38.00
Previous Close 37.80
Day's Range 36.15 - 38.90
52-Week Range 28.80 - 45.80
Beta -0.36
RSI 44.84
Earnings Date Mar 13, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety examination systems, human diagnosis arrays systems, agriculture examination systems, food examination arrays systems, and laboratory instruments, as well as DNA kits. It also offers laboratory planning, design, and other services. In addition, the company engages in the wholesale and retail of contact lenses. The company was formerly known as DR. Chip Biotechnology Incorporation and cha... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 44
Stock Exchange Taipei Exchange
Ticker Symbol 4131
Full Company Profile

Financial Performance

In 2024, NeoCore Technology's revenue was 61.55 million, a decrease of -4.92% compared to the previous year's 64.73 million. Losses were -48.14 million, -25.54% less than in 2023.

Financial Statements

News

There is no news available yet.